<?xml version="1.0" encoding="UTF-8"?>
<p>In December 2012, the US Food and Drug Administration expanded the use of the antiviral oseltamivir phosphate to include infants 2 weeks of age and older for the treatment of uncomplicated influenza 
 <sup>
  <xref rid="ref-79" ref-type="bibr">79</xref>
 </sup>. This is the only antiviral approved for the treatment of influenza in infants but is not indicated for prevention in those younger than 1 year of age, although it can be used prophylactically in children older than 1 year of age at high risk, including those in close contact with individuals with known or suspected influenza infection 
 <sup>
  <xref rid="ref-80" ref-type="bibr">80</xref>
 </sup>.
</p>
